mesenchymal stem cell-derived exosomes (University of California Davis/Karolinska Institutet)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namemesenchymal stem cell-derived exosomes (University of California Davis/Karolinska Institutet)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyBiologics > Exosomes > Stem cell-derived exosomes
Mechanisms of ActionNuclear factor NF-kappa-B complex modulators
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsPeripheral arterial occlusive disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of California Davis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of CaliforniaThe University Of California DavisKarolinska Institutet
Active IndicationsN/A
Inactive IndicationsPeripheral arterial occlusive disorders

Other Information

ATC CodeN/A
Related LinksN/A